1Bernard GR,Artigas A,Brigham K L. et al. The American-European consensus conference on ARDS (Definitions, Mechanisms,Relevant outcomes,and Clinical trial coordination)[J].Am J Respir Crit Care Med, 1994,149 :818-824.
2Lewandowski K, Metz J, Deutschmann C. et al. Incidence, severity,and mortality of acute respiratory failure in Berlin,Germany[J]. Am J Respir Crit Care Med 1995,151:1 121-1 125.
33. Valta P, Uusaro A, Nunea S, et al. Acute respiratory distress syndrome: Frequency, Clinical couse, and Cost of care[J]. Crit care Med, 1999,27(11) :2 364-2 374.
4Jacoba RF,Tabor DR,Burka AW. et al. Elevated intefleukin-1 release by human alveolar macrophagea during the adult respiratory distress syndrome[J]. Am Rev Reapir Dis, 1989,140: 1686- 1 692.
5Suter PM, Suter S,Girardin E, et al. High bronchoalveolar levels of tumor necrosis factor and its inhibitors,interleukin-1 ,interferon,and elastase, in patients with adult respiratory distress syndrome after trauma,shock,or sepsis[J]. Am Rev Respir Dis, 1992,145 : 1 016- 1 022.
6Hyers TM, Tficomi SM, Dettenmeier PA. et al. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome[J]. Am J Respir Crit Care Med, 1991,144 : 268-271.
7Meduri G U, Headley S, Kohler G, et aL Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS[J].Chest, 1995,107 : 1062- 1 073.
8Pugin J, Ricou B, Steinberg K P, et al. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1β[J]. Am J Respir Crit CareMed, 1996,153:1850-1856.
9Meduri GU, Kohler G, Headley S. et aL Inflammatory cytokines in the BAL of patients with ARDS: persistent elevation over time predicts outcome[J]. Chest , 1995, 108, 1303-1314.
10Bauer T,Monton C,Torres A. et al. Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls[J]. Thorax 2000,55:46-52.
10Dellinger RP,Zimmerman JL,Taylor RW,et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: focusing on pulmonary and extrapulmonary forms. Crit Care Med, 1998,26(1):15-23.
